Infusion system for in-line disinfection of prepared infusion substance using ultraviolet light

By designing an infusion system that surrounds the infusion cavity with UV halo, the problem of real-time disinfection in the prior art during medical procedures is solved, real-time disinfection of infusions is achieved, and the risk of blood infection related to infusion is reduced.

CN222092256UActive Publication Date: 2024-12-03BARD ACCESS SYSTEMS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202420235778.X
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Priority Date
2023-02-01
Filing Date
2024-01-31
Publication Date
2024-12-03
Estimated Expiration
2034-01-31

AI Technical Summary

Technical Problem

The existing disinfection system is not suitable for real-time disinfection using UV light during medical procedures, and the infusion cannot be disinfected in real-time inline during infusion, resulting in an increased risk of blood infection related to infusion.

Method used

A infusion system including vascular access equipment and UV aura is designed. The UV aura surrounds the infusion cavity, uses UV light to disinfect the infusion, and powers through electronic circuits and internal/external power supplies. The UV aura can be automatically Adjust size and activate emit UV light.

Benefits of technology

Real-time disinfection of infusions was achieved during the patient's infusion, reducing the risk of blood infection related to infusion and improving the disinfection efficiency of medical equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222092256U_ABST
    Figure CN222092256U_ABST
Patent Text Reader

Abstract

The present application relates to an infusion system for in-line disinfection of a prepared infusion using ultraviolet light, which may include a vascular access device ("VAD") and a UV halo. The VAD may include an intracorporeal conduit, one or more extracorporeal conduits in fluid connection with the intracorporeal conduit, a bushing between a proximal portion of the intracorporeal conduit and one or more respective distal portions of the one or more extracorporeal conduits, and one or more respective connectors of the one or more extracorporeal conduits. The in vivo conduit is configured to be percutaneously inserted within a patient, and the in vitro conduit is configured to remain outside the patient. The UV light ring may be configured to surround a portion of an infusion lumen of the VAD and irradiate the prepared infusion substance within the infusion lumen with UV light for infusing the disinfected infusion substance into the patient during infusion of the patient.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] priority

[0002] This application claims the benefit of priority to U.S. patent application No. 18 / 104,448, filed on February 1, 2023, which is incorporated by reference in its entirety into this application. Technical Field

[0003] The present application relates to the field of medical devices, and more specifically to an infusion system for in-line sterilization of prepared infusions using ultraviolet light. Background Art

[0004] It is well known that ultraviolet ("UV") light damages bacteria and their endotoxins, and this knowledge has been implemented in various disinfection systems (including UV disinfection cabinets and handheld UV lamps) that utilize UV ​​light to disinfect medical devices. Although existing disinfection systems may be highly effective at disinfecting medical devices using UV light prior to use, such existing disinfection systems are not suitable for real-time disinfection using UV light during medical procedures. It follows that existing disinfection systems are also not suitable for real-time in-line disinfection of infusates prepared by a provider or clinician during infusion using UV light, which is desirable for reducing infusion-related bloodstream infections.

[0005] Disclosed herein are infusion systems and methods for in-line sterilization of prepared infusions using UV light. Utility Model Content

[0006] Disclosed herein is an infusion system for in-line sterilization of a prepared infusate using ultraviolet light ("UV light"). The infusion system includes a vascular access device ("VAD") and an ultraviolet light ring ("UV light ring"). The VAD includes an intracorporeal conduit, one or more extracorporeal conduits fluidly connected to the intracorporeal conduit, a sleeve between a proximal portion of the intracorporeal conduit and one or more corresponding distal portions of the one or more extracorporeal conduits, and one or more corresponding connectors of the one or more extracorporeal conduits. The intracorporeal conduit is configured to be percutaneously inserted into a patient's body, and the extracorporeal conduit is configured to remain outside the patient's body. The UV light ring is configured to surround a portion of an infusion lumen of the VAD. The UV light ring is also configured to irradiate the prepared infusate within the infusion lumen with UV light for infusing the sterilized infusate into the patient's body during the patient's infusion.

[0007] In some embodiments, a UV light ring is removably or fixedly connected around an intracorporeal conduit, an extracorporeal conduit in one or more extracorporeal conduits, a sleeve conduit in one or more sleeve conduits that fluidly connect the one or more extracorporeal conduits to the intracorporeal conduit, or a distal luminal surface of a connector in one or more connectors.

[0008] In some embodiments, the UV light ring is removably coupled around the distal luminal surface of the intracorporeal tubing, extracorporeal tubing, liner tubing, or connector. The UV light ring is configured to automatically adjust its size according to the size of the intracorporeal tubing, extracorporeal tubing, liner tubing, or connector.

[0009] In some embodiments, the intracorporeal tubing, extracorporeal tubing, sleeve tubing, or connector around which the UV light ring is fixedly or removably coupled is formed of a material that does not significantly reflect or absorb UV light from the UV light ring.

[0010] In some embodiments, the UV light ring is integrated into the inner cavity surface of an in vivo conduit, an extracorporeal conduit in one or more extracorporeal conduits, a sleeve conduit in one or more sleeve conduits that fluidly connect one or more extracorporeal conduits to an in vivo conduit, or a connector in one or more connectors.

[0011] In some embodiments, the VAD further comprises a fixed or removable internal power source and an electronic circuit between the internal power source and the UV light ring. The electronic circuit is configured to supply power from the internal power source to the UV light ring.

[0012] In some embodiments, the infusion system further comprises a cable and an electronic circuit between the cable and the UV light ring. The cable is configured to be connected to an external power source. The electronic circuit is configured to supply power to the UV light ring.

[0013] In some embodiments, the infusion system further comprises an indicator light operably connected to the electronic circuit. The indicator light is configured to emit visible light when the UV light ring emits UV light.

[0014] In some embodiments, the UV light ring is configured to automatically emit UV light upon an activation event, the activation event being selected from an assembly step when assembling the VAD, a connection step when connecting the VAD to an infusion bag containing a prepared infusate, or a start-up step of infusing the prepared infusate into a patient through an infusion lumen.

[0015] In some embodiments, the VAD is a catheter. The intracorporeal conduit, one or more extracorporeal conduits, the hub, and one or more connectors correspond to the catheter tubing, one or more extension legs, the catheter hub, and one or more Luer connectors of the catheter, respectively.

[0016] In some embodiments, the VAD is a Huber needle set. The intracorporeal tubing, one or more extracorporeal tubings, the hub, and one or more connectors correspond to the needle, extension tubing, needle hub, and Luer connector of the Huber needle set, respectively.

[0017] Also disclosed herein is a method for an infusion system that uses UV light to sterilize a prepared infusion in-line. The method includes a VAD acquisition step, a VAD connection step, and an infusion step. The VAD acquisition step includes obtaining a VAD of an infusion system. The VAD includes an in vivo conduit, one or more extracorporeal conduits fluidly connected to the in vivo conduit, a sleeve between a proximal portion of the in vivo conduit and one or more corresponding distal portions of one or more extracorporeal conduits, and one or more corresponding connectors of the one or more extracorporeal conduits. The in vivo conduit is configured to be percutaneously inserted into a patient, and the extracorporeal conduit is configured to remain outside the patient. The VAD connection step includes connecting the VAD to an infusion bag containing the prepared infusion. The infusion step includes infusing the patient with the sterilized infusion. The sterilized infusion is produced by irradiating the prepared infusion in the infusion lumen with UV light from a UV light ring that is a portion of the infusion lumen surrounding the VAD.

[0018] In some embodiments, a UV light ring is removably or fixedly connected around an intracorporeal conduit, an extracorporeal conduit in one or more extracorporeal conduits, a sleeve conduit in one or more sleeve conduits that fluidly connect the one or more extracorporeal conduits to the intracorporeal conduit, or a distal luminal surface of a connector in one or more connectors.

[0019] In some embodiments, the method further comprises a light ring placement step. The light ring placement step comprises placing the UV light ring on the distal luminal surface of the intracorporeal tubing, extracorporeal tubing, liner tubing, or connector, thereby removably coupling the UV light ring to the VAD. The UV light ring is configured to automatically adjust its size according to the size of the intracorporeal tubing, extracorporeal tubing, liner tubing, or connector.

[0020] In some embodiments, the intracorporeal tubing, extracorporeal tubing, sleeve tubing, or connector around which the UV light ring is fixedly or removably coupled is formed of a material that does not significantly reflect or absorb UV light from the UV light ring.

[0021] In some embodiments, the UV light ring is integrated into the inner cavity surface of an in vivo conduit, an extracorporeal conduit in one or more extracorporeal conduits, a sleeve conduit in one or more sleeve conduits that fluidly connect one or more extracorporeal conduits to an in vivo conduit, or a connector in one or more connectors.

[0022] In some embodiments, the VAD further comprises a fixed or removable internal power source and an electronic circuit between the internal power source and the UV light ring. The electronic circuit is configured to supply power from the internal power source to the UV light ring.

[0023] In some embodiments, the method further comprises a cabling step. The cabling step comprises connecting the cable to an external power source. The electronic circuit between the cable and the UV light ring is configured to supply power to the UV light ring.

[0024] In some embodiments, an indicator light operably connected to the electronic circuit is configured to emit visible light when the UV light ring emits UV light.

[0025] In some embodiments, the UV light ring is configured to automatically emit UV light upon an activation event, the activation event being selected from an assembly step when assembling the VAD, a VAD connection step when connecting the VAD to an infusion bag, or an infusion step of initiating an infusion of a patient using a sterilized infusate.

[0026] In some embodiments, the VAD is a catheter. The intracorporeal conduit, one or more extracorporeal conduits, the hub, and one or more connectors correspond to the catheter tubing, one or more extension legs, the catheter hub, and one or more Luer connectors of the catheter, respectively.

[0027] In some embodiments, the VAD is a Huber needle set. The intracorporeal tubing, one or more extracorporeal tubings, the hub, and one or more connectors correspond to the needle, extension tubing, needle hub, and Luer connector of the Huber needle set, respectively.

[0028] In some embodiments, the VAD is a Huber needle set. The intracorporeal tubing, one or more extracorporeal tubings, the hub, and one or more connectors correspond to the needle, extension tubing, needle hub, and Luer connector of the Huber needle set, respectively.

[0029] These and other features of the concepts provided herein will become more readily apparent to those skilled in the art in view of the accompanying drawings and the following description, which describe in more detail specific embodiments of such concepts. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 An infusion to a patient is shown with an infusion system that utilizes UV light to sterilize the prepared infusate in-line, according to some embodiments.

[0031] Figure 2 A central venous catheter for a VAD infusion system is shown according to some embodiments.

[0032] Figure 3 Another VAD Huber needle set for use with an infusion system is shown, according to some embodiments.

[0033] Figure 4 A transverse cross-section of a UV light ring around the distal luminal surface of a VAD is shown, according to some embodiments.

[0034] Figure 5 Shown is a transverse cross-section of a UV light ring integrated into the lumen surface of a VAD, according to some embodiments.

[0035] Figure 6 An internal power source and electronic circuitry between the internal power source and the UV light ring are shown according to some embodiments. DETAILED DESCRIPTION

[0036] Before disclosing some specific embodiments in more detail, it should be understood that the specific embodiments disclosed herein do not limit the scope of the concepts provided herein. It should also be understood that the specific embodiments disclosed herein may have features that can be easily separated from the specific embodiments, and these features may be optionally combined with or replace the features of any of the many other embodiments disclosed herein.

[0037] About the terms used herein, it should also be understood that these terms are for the purpose of describing some specific embodiments, and these terms do not limit the scope of the concepts provided herein.Ordinal numbers (e.g., first, second, third, etc.) are generally used to distinguish or identify different features or steps in a set of features or steps, and do not provide sequence or numerical restrictions.For example, "first", "second" and "third" features or steps do not necessarily appear in this order, and the specific embodiments including such features or steps are not necessarily limited to these three features or steps.In addition, unless otherwise specified, any feature or step in the aforementioned features or steps and then can also include one or more features or steps.For convenience, using labels such as "left", "right", "top", "bottom", "front", "back", etc., these labels are not intended to imply, for example, any specific fixed position, orientation or direction.On the contrary, such labels are used to reflect, for example, relative position, orientation or direction.Singular forms of "a kind of", "one" and "the" include plural references unless the context clearly specifies otherwise.

[0038] "Proximal" is used to indicate a portion, segment, component, element, etc. of a medical device that is intended to be placed near or relatively close to a clinician when the medical device is used on a patient. For example, a "proximal portion" or "proximal segment" of a medical device includes a portion or segment of a medical device that is intended to be placed near a clinician when the medical device is used on a patient. Similarly, a "proximal length" of a medical device includes a length of a medical device that is intended to be placed near a clinician when the medical device is used on a patient. The "proximal end" of a medical device includes an end of a medical device that is intended to be placed near a clinician when the medical device is used on a patient. The proximal portion, proximal segment, or proximal length of a medical device need not include the proximal end of the medical device. In fact, the proximal portion, proximal segment, or proximal length of a medical device may be shorter than the proximal end of the medical device. However, the proximal portion, proximal segment, or proximal length of a medical device may include the proximal end of the medical device. If the context does not indicate that the proximal portion, proximal segment, or proximal length of a medical device includes the proximal end of the medical device, or if deemed advantageous in the following description, the "proximal portion," "proximal segment," or "proximal length" may be modified to indicate that such portion, segment, or length includes the end portion, end segment, or end length, respectively, of the medical device to refer to the "proximal portion," "proximal segment," or "proximal length" of the medical device.

[0039] "Distal" is used to indicate that the part, segment, component, element, etc. of the medical device is intended to be placed near the patient, relatively close to the patient, or even in the patient's body when the medical device is used for the patient. For example, the "distal part" or "distal segment" of the medical device includes the part or segment of the medical device intended to be placed near the patient, relatively close to the patient, or even in the patient's body when the medical device is used for the patient. Similarly, the "distal length" of the medical device includes the length of the medical device intended to be placed near the patient, relatively close to the patient, or even in the patient's body when the medical device is used for the patient. The "distal end" of the medical device is the end of the medical device intended to be placed near the patient, relatively close to the patient, or even in the patient's body when the medical device is used for the patient. The distal part, distal segment, or distal length of the medical device does not need to include the distal end of the medical device. In fact, the distal part, distal segment, or distal length of the medical device can be shorter than the distal end of the medical device. However, the distal part, distal segment, or distal length of the medical device can include the distal end of the medical device. If the context does not indicate that the distal portion, distal segment, or distal length of a medical device includes the distal end of the medical device, or if deemed advantageous in the following description, the "distal portion," "distal segment," or "distal length" may be modified to indicate that such portion, segment, or length includes the end portion, end segment, or end length, respectively, of the medical device to refer to the "distal portion," "distal segment," or "distal length" of the medical device.

[0040] Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art.

[0041] Likewise, it is well known that UV light damages bacteria and their endotoxins, and this knowledge has been implemented in various disinfection systems (including UV disinfection cabinets and handheld UV lamps) that utilize UV ​​light to disinfect medical devices. While existing disinfection systems may be highly effective at disinfecting medical devices using UV light prior to use, such existing disinfection systems are not suitable for real-time disinfection using UV light during medical procedures. It follows that existing disinfection systems are also not suitable for real-time in-line disinfection of infusates prepared by suppliers or clinicians using UV light during infusions, which is desirable for reducing bloodstream infections associated with infusions.

[0042] Disclosed herein are infusion systems and methods for in-line sterilization of prepared infusions using UV light.

[0043] Infusion System

[0044] Figure 1 According to some embodiments, a method for utilizing UV light ( Figure 4 and Figure 5 The infusion system 100 ("hv" in the figure) performs an infusion on a patient P by performing in-line sterilization on the prepared infusion 102. Figure 2 and Figure 3 A central venous catheter and a Huber needle set are shown, respectively, for use with the VAD 104 of the infusion system 100 according to some embodiments.

[0045] As shown, the infusion system 100 includes a VAD 104 and a UV light ring 106, which is either integrated with the VAD 104 or separate from the VAD 104 but configured to be coupled to the VAD 104. Figure 2 and Figure 3 1 and 2. Several options for placing UV light ring 106 around or within VAD 104 are shown in FIG. However, it should be understood that VAD 104 may include two or more such UV light rings as desired.

[0046] The VAD 104 includes an intracorporeal conduit 108, one or more extracorporeal conduits 110 fluidly connected to the intracorporeal conduit 108, a sleeve 112 between a proximal portion of the intracorporeal conduit 108 and one or more corresponding distal portions of the one or more extracorporeal conduits 110, and one or more corresponding connectors 114 of the one or more extracorporeal conduits 110. At least a portion of the intracorporeal conduit 108 is configured to be percutaneously inserted into the body of the patient P. In contrast, the entire extracorporeal conduit is configured to remain external to the patient P.

[0047] Figure 2 The VAD 104 is shown as a central venous catheter; however, the VAD 104 may be any of a number of other catheters, including a peripherally inserted central catheter, a peripheral intravenous catheter, etc. Figure 2 In the central venous catheter shown in FIG, the in vivo tubing 108, one or more extracorporeal tubing 110, the hub 112 and one or more connectors 114 correspond to the catheter tubing, one or more extension legs, the catheter hub and one or more Luer connectors of the central venous catheter, respectively.

[0048] Figure 3 The VAD 104 may be used to enter Figure 1 The Huber needle set of the implantable vascular access port mentioned in the above; however, the VAD 104 can be any of many other infusion sets. Figure 3 In the Huber needle set shown in FIG. 1 , the intracorporeal tubing 108, the one or more extracorporeal tubings 110, the hub 112, and the one or more connectors 114 correspond to the needle, extension tube, needle hub, and Luer connector of the Huber needle set, respectively.

[0049] Likewise, the UV light ring 106 is either integrated with the VAD 104 or separate from but configured to be coupled to the VAD 104. In any case, the UV light ring 106 is configured to surround a portion of the infusion lumen 116 of the VAD 104. Furthermore, the UV light ring 106 is configured to irradiate the prepared infusate 102 with UV light from the UV light ring when the prepared infusate 102 is present within the infusion lumen 116 of the VAD 104, thereby allowing the sterilized infusate to be infused into the patient P during the infusion of the patient P.

[0050] It is worth noting that the UV light ring 106 can be configured to emit UV light in a range from about 100nm to about 280nm, which corresponds to the so-called UVC range; however, the UV light ring 106 does not need to be limited to emitting the UVC range. In fact, the UV light ring 106 can be configured to emit UV light of any wavelength in the UV portion of the electromagnetic spectrum. In one example, the UV light ring 106 can alternatively be configured to emit UV light in a range from about 280nm to about 315nm, which corresponds to the so-called UVB range. In another example, the UV light ring 106 can alternatively be configured to emit UV light in a range from about 315nm to about 400nm, which corresponds to the so-called UVA range. Considering that the UV light ring 106 is configured to emit UV light in the UVC range, the UV light ring 106 may include one or more light emitting diodes ("LEDs") arranged in the sealed annular duct 118, which LEDs can independently have an emission peak at any wavelength in the UVC range, such as 265nm, 273nm or 280nm. Such an LED advantageously allows the UV light emitted from the UV light ring 106 to be selected to provide a wider range (e.g., 265nm to 280nm), a narrower range (e.g., 265nm to 273nm or 273nm to 280nm), or even a gap range (e.g., 265nm to 280nm with a gap around 273nm) as desired to accommodate components of the VAD 104 formed of UV light-sensitive materials or even drugs including UV light-sensitive molecular entities. That is, at least the VAD 104 (and specifically, the components of the VAD 104 including the UV light ring 106) including the UV light ring 106 integrated therein or fixedly coupled thereto can be formed of one or more materials that are sufficiently inert to the UV light of the UV light ring 106.

[0051] Figure 4 A transverse cross-section of a UV light ring 106 around the distal luminal surface of a VAD 104 is shown, according to some embodiments.

[0052] As shown, the UV light ring 106 can be removably or fixedly connected around the distal luminal surface of the intracorporeal tubing 108 but proximally of a portion of the intracorporeal tubing 108 intended to be placed in the patient P. Alternatively, the UV light ring 106 can be removably or fixedly connected around the distal luminal surface of the extracorporeal tubing in one or more extracorporeal tubings 110, the liner tubing in one or more liner tubings that fluidly connect one or more extracorporeal tubings 110 to the intracorporeal tubing 108, or the connector in one or more connectors 114. Considering that the UV light ring 106 is removably connected around the distal luminal surface of the intracorporeal tubing 108, the extracorporeal tubing, the liner tubing, or the connector, the UV light ring 106 can be configured to automatically adjust its size according to the size of the intracorporeal tubing 108, the extracorporeal tubing, the liner tubing, or the connector. However, in other embodiments, the UV light ring 106 is manufactured in different sizes for connecting the UV light ring 106 around the distal luminal surface of the intracorporeal tubing 108, the extracorporeal tubing, the liner tubing, or the connector of a larger or smaller VAD. Notably, the in vivo tubing 108 , extracorporeal tubing, sleeve tubing, or connector around which the UV light ring 106 is fixedly or removably coupled should be formed of a material that does not significantly reflect or absorb UV light from the UV light ring 106 .

[0053] Figure 5 A transverse cross-section of a UV light ring 106 integrated into the lumen surface of a VAD 104 is shown, according to some embodiments.

[0054] As shown, the UV light ring 106 can be integrated into the lumen surface of the intracorporeal tubing 108, the extracorporeal tubing of one or more extracorporeal tubings 110, the liner tubing of one or more liner tubings fluidly connecting the one or more extracorporeal tubings 110 to the intracorporeal tubing 108, or the connector of one or more connectors 114. When the UV light ring 106 is integrated into the lumen surface of the intracorporeal tubing 108, the extracorporeal tubing, the liner tubing, or the connector, the UV light is advantageously contained, thereby reducing or eliminating clinician or patient exposure.

[0055] Figure 6 An internal power source 120 (eg, a battery) and electronic circuitry 122 are shown according to some embodiments.

[0056] As shown, the VAD 104 may include a fixed or removable internal power source for the internal power source 120 and electronic circuitry 122 between the internal power source 120 and the UV light ring 106 .

[0057] Alternatively, the infusion system 100 or VAD 104 itself may include a cable and electronic circuitry 122 between the cable and the UV light ring 106. The cable is configured with a plug for connecting to an external power source. Whether the VAD 104 includes an internal power source 120 or utilizes a cable, the electronic circuitry 122 is configured to provide power to the UV light ring 106 from the power source.

[0058] like Figure 2 and Figure 3 As shown, the infusion system 100 or VAD 104 itself may include an indicator light 124 operably connected to the electronic circuit 122. Since UV light is invisible to the human eye, the indicator light 124 is configured to emit visible light as an indicator of UV light when the UV light ring 106 emits UV light.

[0059] Notably, as described in the following method, the UV light ring 106 can be configured to automatically emit UV light upon an activation event, the activation event being selected from an assembly step when assembling the VAD 104 (e.g., connecting the UV light ring 106 to the VAD 104), a connection step when connecting the VAD 104 to an infusion bag 126 containing the prepared infusate 102, or a start-up step of infusing the prepared infusate 102 into the patient P through the infusion lumen 116.

[0060] method

[0061] The method includes a method of infusion system 100, such as in-line sterilization of prepared infusate (e.g., prepared infusate 102) in real-time using UV light during infusion of a patient (e.g., patient P). Such a method may include one or more steps selected from the following: a VAD acquisition step, a VAD connection step, a light ring placement step, a cable connection step, and an infusion step.

[0062] The VAD obtaining step includes obtaining the VAD 104 of the infusion system 100. As described above, the VAD 104 includes an intracorporeal conduit 108, one or more extracorporeal conduits 110 fluidly connected to the intracorporeal conduit 108, a sleeve 112 between a proximal portion of the intracorporeal conduit 108 and one or more corresponding distal portions of the one or more extracorporeal conduits 110, and one or more corresponding connectors 114 of the one or more extracorporeal conduits 110.

[0063] If the UV light ring 106 is not integrated with or fixedly coupled to the VAD 104, the method may include a light ring placement step. The light ring placement step includes placing the UV light ring 106 on the distal luminal surface of the intracorporeal tubing 108, extracorporeal tubing, liner tubing, or connector, thereby removably coupling the UV light ring 106 to the VAD 104. As described above, the UV light ring 106 may be configured to automatically adjust its size based on the size of the intracorporeal tubing 108, extracorporeal tubing, liner tubing, or connector.

[0064] The VAD connection step includes connecting the VAD 104 to an infusion bag 126 containing the prepared infusate 102 .

[0065] If the VAD 104 does not include an internal power source 120, or as an alternative thereto, the method may include a cabling step. The cabling step includes connecting a cable (if present) to an external power source. An electronic circuit 122 between the cable and the UV light ring 106 is configured to provide power to the UV light ring 106.

[0066] The infusion step includes infusing the patient P with a sterile infusate. The sterile infusate is produced by irradiating the prepared infusate 102 within the infusion lumen 116 with UV light from a UV light ring 106 surrounding a portion of the infusion lumen 116 of the VAD 104.

[0067] (See Figure 4 and Figure 5 ).

[0068] Notably, as described above, the VAD 104 may include an indicator light 124 operably connected to the electronic circuit 122 for emitting visible light when the UV light ring 106 emits UV light. The UV light ring 106 may be further configured to automatically emit UV light upon an activation event, the activation event being selected from an assembly step when assembling the VAD 104, a VAD connection step when connecting the VAD 104 to an infusion bag 126, or an infusion step to initiate an infusion of the patient P with a sterilized infusate.

[0069] Although some specific embodiments have been disclosed herein, and although these specific embodiments have been disclosed in considerable detail, these specific embodiments are not intended to limit the scope of the concepts provided herein. Additional adaptations or modifications may be envisioned by those of ordinary skill in the art, and in broader aspects, these adaptations or modifications are also encompassed. Therefore, changes may be made to the specific embodiments disclosed herein without departing from the scope of the concepts provided herein.

Claims

1. An infusion system for in-line sterilization of prepared infusions using ultraviolet light, characterized in that: The infusion system comprises: A vascular access device, the vascular access device comprising: an intracorporeal conduit configured to be percutaneously inserted into a patient's body; one or more extracorporeal conduits fluidly connected to the intracorporeal conduits, the extracorporeal conduits being configured to remain outside the patient's body; a sleeve positioned between a distal portion of the intracorporeal conduit and one or more corresponding distal portions of the one or more extracorporeal conduits; and one or more corresponding connectors of the one or more extracorporeal tubes; and a UV ring configured to surround a portion of an infusion lumen of the vascular access device and illuminate the prepared infusion within the infusion lumen with UV light so as to infuse the sterilized infusion into the patient during infusion of the patient.

2. The infusion system according to claim 1, characterized in that The ultraviolet light ring is removably or fixedly connected around the distal lumen surface of the in vivo tube, the extracorporeal tube of the one or more extracorporeal tubes, the sleeve tube of one or more sleeve tubes fluidically connecting the one or more extracorporeal tubes to the in vivo tube, or the connector of the one or more connectors.

3. The infusion system according to claim 2, characterized in that The ultraviolet light ring is removably connected around the distal luminal surface of the intracorporeal tubing, the extracorporeal tubing, the sleeve tubing or the connector, and the ultraviolet light ring is configured to automatically adjust the size of the ultraviolet light ring according to the size of the intracorporeal tubing, the extracorporeal tubing, the sleeve tubing or the connector.

4. The infusion system according to claim 2, characterized in that The intracorporeal tubing, the extracorporeal tubing, the sleeve tubing, or the connector around which the UV ring is fixedly or removably coupled is formed of a material that does not significantly reflect or absorb UV light from the UV ring.

5. The infusion system according to claim 1, characterized in that The ultraviolet light ring is integrated into the inner cavity surface of the in vivo pipe, the extracorporeal pipe of the one or more extracorporeal pipes, the sleeve pipe of one or more sleeve pipes that respectively fluidically connect the one or more extracorporeal pipes to the in vivo pipe, or the connector of the one or more connectors.

6. The infusion system according to claim 1, characterized in that The vascular access device also includes a fixed or removable internal power source, and electronic circuitry between the internal power source and the ultraviolet light ring, the electronic circuitry being configured to supply power from the internal power source to the ultraviolet light ring.

7. The infusion system according to claim 1, characterized in that Also included is a cable configured to be connected to an external power source, and electronic circuitry between the cable and the ultraviolet light ring to power the ultraviolet light ring.

8. The infusion system according to claim 6, characterized in that Also included is an indicator light operably connected to the electronic circuit, the indicator light being configured to emit visible light when the ultraviolet light ring emits ultraviolet light.

9. The infusion system according to claim 1, characterized in that: The UV light ring is configured to automatically emit UV light upon an activation event, wherein the activation event is selected from an assembly step when assembling the vascular access device, a connection step when connecting the vascular access device to an infusion bag containing the prepared infusate, or a start-up step of infusing the prepared infusate into the patient's body through the infusion lumen.

10. The infusion system according to claim 1, characterized in that The vascular access device is a catheter, and the intracorporeal conduit, the one or more extracorporeal conduits, the hub and the one or more connectors are respectively a catheter tube, one or more extension legs, a catheter hub and one or more Luer connectors.

11. The infusion system according to claim 1, characterized in that The vascular access device is a Huber needle set, and the intracorporeal conduit, the one or more extracorporeal conduits, the hub and the one or more connectors are a needle, an extension tube, a needle hub and a Luer connector, respectively.